Loading organizations...
§ Private Profile · Innsbruck, Tirol, Austria
Develops anti-cancer therapeutics using oncolytic viruses.
Vira Therapeutics has raised $4.0M across 1 funding round.
Vira Therapeutics has raised $4.0M in total across 1 funding round.
Vira Therapeutics has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in June 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 24, 2015 | $4M Series A | Boehringer Ingelheim, EMBL Ventures | Austria Wirtschaftsservice | Announced |
Vira Therapeutics has raised $4.0M in total across 1 funding round.
Vira Therapeutics's investors include Boehringer Ingelheim, EMBL Ventures, Austria Wirtschaftsservice.